[go: up one dir, main page]

WO2002032876A3 - Neue m-amino-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz - Google Patents

Neue m-amino-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz Download PDF

Info

Publication number
WO2002032876A3
WO2002032876A3 PCT/EP2001/011764 EP0111764W WO0232876A3 WO 2002032876 A3 WO2002032876 A3 WO 2002032876A3 EP 0111764 W EP0111764 W EP 0111764W WO 0232876 A3 WO0232876 A3 WO 0232876A3
Authority
WO
WIPO (PCT)
Prior art keywords
phenylimino
amino
urinary incontinence
novel
treating urinary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/011764
Other languages
English (en)
French (fr)
Other versions
WO2002032876A2 (de
Inventor
Franz Esser
Pascale Arielle Jane-Jo Pouzet
Hisato Kitagawa
Kenji Sakai
Ikunobu Muramatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2002536060A priority Critical patent/JP2004511547A/ja
Priority to BR0114603-3A priority patent/BR0114603A/pt
Priority to IL15533801A priority patent/IL155338A0/xx
Priority to HU0302245A priority patent/HUP0302245A3/hu
Priority to SK434-2003A priority patent/SK4342003A3/sk
Priority to AU2002215943A priority patent/AU2002215943A1/en
Priority to EA200300460A priority patent/EA200300460A1/ru
Priority to PL01361359A priority patent/PL361359A1/xx
Priority to KR10-2003-7005143A priority patent/KR20030046503A/ko
Priority to EEP200300177A priority patent/EE200300177A/xx
Priority to CA002425563A priority patent/CA2425563A1/en
Priority to EP01987747A priority patent/EP1328517A2/de
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Priority to MXPA03003162A priority patent/MXPA03003162A/es
Publication of WO2002032876A2 publication Critical patent/WO2002032876A2/de
Publication of WO2002032876A3 publication Critical patent/WO2002032876A3/de
Priority to BG107711A priority patent/BG107711A/xx
Priority to NO20031697A priority patent/NO20031697L/no
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Die vorliegende Erfindung betrifft m-Amino-phenylimino-imidazolidin-Derivate mit neuem Substituentenmuster am Phenylring, der allgemeinen Formel (I) oder der allgemeinen Formel (II) mit R1: F, Cl, Br, CH2F, CF2H oder CF3; R2: NR6R7, mit R6: Me, Et, Pr oder iPr; R7: Me, Et oder Pr, R3, R4, R5: sind jeweils unabhängig voneinander H, Me, F, Cl, Br, CH2F, CF2H und/oder CF3 und für den Fall, daß R4: Me, F, Cl, Br, CH2F, CF2H oder CF3 ist, dann ist R1 zusätzlich auch H oder Me und/oder deren pharmakologisch verträgliches Salz, ihrer Verwendung zur Herstellung von Arzneimitteln, insbesondere zur Behandlung der Harninkontinenz und Herstellungsverfahren derselben.
PCT/EP2001/011764 2000-10-14 2001-10-11 Neue m-amino-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz Ceased WO2002032876A2 (de)

Priority Applications (15)

Application Number Priority Date Filing Date Title
BR0114603-3A BR0114603A (pt) 2000-10-14 2001-10-11 Derivados de m-amino-fenilimino-imidazolidina para tratamento da incontinência urinária
IL15533801A IL155338A0 (en) 2000-10-14 2001-10-11 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
HU0302245A HUP0302245A3 (en) 2000-10-14 2001-10-11 Novel m-amino-phenylimino-imidazolidine derivatives, their use and pharmaceutical compositions for treating urinary incontinence
SK434-2003A SK4342003A3 (en) 2000-10-14 2001-10-11 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
AU2002215943A AU2002215943A1 (en) 2000-10-14 2001-10-11 Novel M-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
EA200300460A EA200300460A1 (ru) 2000-10-14 2001-10-11 НОВЫЕ ПРОИЗВОДНЫЕ м-АМИНОФЕНИЛИМИНОИМИДАЗОЛИДИНА ДЛЯ ЛЕЧЕНИЯ НЕДЕРЖАНИЯ МОЧИ
PL01361359A PL361359A1 (en) 2000-10-14 2001-10-11 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
EEP200300177A EE200300177A (et) 2000-10-14 2001-10-11 m-aminofenüüliminoimidasolidiinderivaadid uriinipidamatuse raviks
KR10-2003-7005143A KR20030046503A (ko) 2000-10-14 2001-10-11 요실금 치료용의 신규한ｍ-아미노-페닐이미노-이미다졸리딘 유도체
JP2002536060A JP2004511547A (ja) 2000-10-14 2001-10-11 尿失禁治療用の新規ｍ−アミノ−フェニルイミノ−イミダゾリジン誘導体
EP01987747A EP1328517A2 (de) 2000-10-14 2001-10-11 Neue m-amino-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz
CA002425563A CA2425563A1 (en) 2000-10-14 2001-10-11 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
MXPA03003162A MXPA03003162A (es) 2000-10-14 2001-10-11 Nuevos derivados de m-amino-fenil-imidazolidina para el tratamiento de la incontinencia de orina.
BG107711A BG107711A (bg) 2000-10-14 2003-04-08 Нови м-амино-фенилимино-имидазолидин-производни за лечение на инконтиненция на урина
NO20031697A NO20031697L (no) 2000-10-14 2003-04-11 Nye m-amino-fenylimino-imidazolin-derivater for behandling av urininkontinens

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14
DE10051005.1 2000-10-14

Publications (2)

Publication Number Publication Date
WO2002032876A2 WO2002032876A2 (de) 2002-04-25
WO2002032876A3 true WO2002032876A3 (de) 2002-07-18

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/011764 Ceased WO2002032876A2 (de) 2000-10-14 2001-10-11 Neue m-amino-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz

Country Status (23)

Country Link
EP (1) EP1328517A2 (de)
JP (1) JP2004511547A (de)
KR (1) KR20030046503A (de)
CN (1) CN1471514A (de)
AR (1) AR035923A1 (de)
AU (1) AU2002215943A1 (de)
BG (1) BG107711A (de)
BR (1) BR0114603A (de)
CA (1) CA2425563A1 (de)
CZ (1) CZ20031333A3 (de)
DE (1) DE10150312A1 (de)
EA (1) EA200300460A1 (de)
EC (1) ECSP034517A (de)
EE (1) EE200300177A (de)
HU (1) HUP0302245A3 (de)
IL (1) IL155338A0 (de)
MX (1) MXPA03003162A (de)
NO (1) NO20031697L (de)
PL (1) PL361359A1 (de)
SK (1) SK4342003A3 (de)
WO (1) WO2002032876A2 (de)
YU (1) YU28203A (de)
ZA (1) ZA200302345B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
EP0081924A1 (de) * 1981-11-20 1983-06-22 Alcon Laboratories, Inc. Lokale Zusammensetzungen zur Reduktion intraokularen Druckes
WO1996032939A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg VERWENDUNG VON α1L-AGONISTEN ZUR BEHANDLUNG DER HARNINKONTINENZ

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
EP0081924A1 (de) * 1981-11-20 1983-06-22 Alcon Laboratories, Inc. Lokale Zusammensetzungen zur Reduktion intraokularen Druckes
WO1996032939A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg VERWENDUNG VON α1L-AGONISTEN ZUR BEHANDLUNG DER HARNINKONTINENZ

Also Published As

Publication number Publication date
KR20030046503A (ko) 2003-06-12
NO20031697D0 (no) 2003-04-11
DE10150312A1 (de) 2002-07-04
MXPA03003162A (es) 2004-12-06
SK4342003A3 (en) 2003-10-07
ECSP034517A (es) 2003-04-25
HUP0302245A2 (hu) 2003-10-28
ZA200302345B (en) 2004-04-23
WO2002032876A2 (de) 2002-04-25
CA2425563A1 (en) 2002-04-25
AU2002215943A1 (en) 2002-04-29
CZ20031333A3 (cs) 2003-08-13
HUP0302245A3 (en) 2004-01-28
EA200300460A1 (ru) 2004-02-26
EP1328517A2 (de) 2003-07-23
AR035923A1 (es) 2004-07-28
CN1471514A (zh) 2004-01-28
EE200300177A (et) 2003-08-15
JP2004511547A (ja) 2004-04-15
IL155338A0 (en) 2003-11-23
YU28203A (sh) 2006-05-25
BG107711A (bg) 2004-02-27
NO20031697L (no) 2003-05-26
BR0114603A (pt) 2003-10-14
PL361359A1 (en) 2004-10-04

Similar Documents

Publication Publication Date Title
EP1527049B8 (de) Kondensierte heterozyklische verbindungen als petidase inhibitoren
WO2002057252A3 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
WO2001019798A3 (en) Inhibitors of factor xa
WO2000071510A3 (en) INHIBITORS OF FACTOR Xa
SI1465861T1 (sl) Alfa-(n-sulfonamido)acetamidni derivati kot beta-amiloid inhibitorji
YU69902A (sh) Novi derivati piperazina
CA2379747A1 (en) Novel succinate derivative compounds useful as cysteine protease inhibitors
WO2001019788A3 (en) BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
WO1997047270A3 (en) Novel anti-viral compounds
DE69835877D1 (de) Trizyklische verbindungen
WO2003014110A1 (en) Benzazepine derivative, process for producing the same, and use
WO2004063330A3 (en) (2-carboxamido) (3-amino) thiophene compounds
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
WO2003064443A3 (en) New corticosteroids
YU30603A (sh) Derivati premošćenog piperazina
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
WO2002032876A3 (de) Neue m-amino-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz
EP1216988A4 (de) Thioalkylamin-derivate und verfahren zu ihrer herstellung
ID30435A (id) Proses-proses untuk menyiapkan perantara-perantara pestisidal
EP1364945A4 (de) Benzimidazolidinonderivate
MXPA04003086A (es) Proceso para sintesis estereoselectiva de 2-hidroximetil-cromanos.
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
NO20031046D0 (no) Fremgangsmåte for fremstilling av en substituert imidazopyridinforbindelse
SE0000382D0 (sv) New process
AP2001002195A0 (en) Novel process for the preparation of pyrazolopyrimidinones.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: P-282/03

Country of ref document: YU

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001987747

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003/02345

Country of ref document: ZA

Ref document number: 200302345

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 503/DELNP/2003

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 10771101

Country of ref document: BG

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 018170870

Country of ref document: CN

Ref document number: 4342003

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: 155338

Country of ref document: IL

Ref document number: PA/a/2003/003162

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2425563

Country of ref document: CA

Ref document number: 1020037005143

Country of ref document: KR

Ref document number: P20030279A

Country of ref document: HR

Ref document number: 1200300350

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: 2002536060

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002215943

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 525782

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 200300460

Country of ref document: EA

ENP Entry into the national phase

Ref document number: 20030782

Country of ref document: UZ

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV2003-1333

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1020037005143

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001987747

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV2003-1333

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 1-2003-500235

Country of ref document: PH

WWR Wipo information: refused in national office

Ref document number: PV2003-1333

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 2001987747

Country of ref document: EP